Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3038-3048

  Bohannon, Julia ^a   Cui, Weihua ^a   Cox, Robert ^a,b   Przkora, Rene ^b   Sherwood, Edward ^a,b   Toliver Kinsky, Tracy ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CD69 ANTIGEN; FLT3 LIGAND; INTERLEUKIN 2 RECEPTOR ALPHA; FLT3 LIGAND PROTEIN; FLT3 PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; LIGAND; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURN; BURN INFECTION; CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; DRUG EFFECT; EXPERIMENTAL MOUSE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION SENSITIVITY; INOCULATION; LANGERHANS CELL; LEUKOCYTE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL RATE; T LYMPHOCYTE; WOUND HEALING; ANIMAL; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; ENZYMOLOGY; GRAM NEGATIVE INFECTION; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SPLEEN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BURNS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; FMS-LIKE TYROSINE KINASE 3; LANGERHANS CELLS; LIGANDS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PSEUDOMONAS INFECTIONS; SPLEEN;

EID: 49149091748     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3038     Document Type: Article

References (64)

1. Loose, L. D., R. Megirian, and J. Turinsky. 1984. Biochemical and functional alterations in macrophages after thermal injury. Infect. Immun. 44: 554-558.
2. Ogle, C. K., C. Johnson, X. L. Guo, J. D. Ogle, J. S. Solomkin, and J. W. Alexander. 1989. Production and release of C3 by cultured monocytes/macrophages isolated from burned, trauma, and septic patients. J. Trauma 29: 189-194.
3. Rodeberg, D. A., R. C. Bass, J. W. Alexander, G. D. Warden, and G. F. Babcock. 1997. Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J. Leukocyte Biol. 61: 575-582.
4. Bender, B. S., R. A. Winchurch, J. N. Thupari, J. J. Proust, W. H. Adler, and A. M. Munster. 1988. Depressed natural killer cell function in thermally injured adults: successful in vivo and in vitro immunomodulation and the role of endotoxin. Clin. Exp. Immunol. 71: 120-125.
5. Klimpel, G. R., D. N. Herndon, M. Fons, T. Albrecht, M. T. Asuncion, R. Chin, and M. D. Stein. 1986. Defective NK cell activity following thermal injury. Clin. Exp. Immunol. 66: 384-392.
6. Lyons, A., J. L. Kelly, M. L. Rodrick, J. A. Mannick, and J. A. Lederer. 1997. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann. Surg. 226: 450-458.
7. O'Sullivan, S. T., J. A. Lederer, A. F. Horgan, D. H. Chin, J. A. Mannick, and M. L. Rodrick. 1995. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222: 482-490.
8. Sachse, C., M. Prigge, G. Cramer, N. Pallua, and E. Henkel. 1999. Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin. Chem. Lab. Med. 37: 193-198.
9. Paterson, H. M., T. J. Murphy, E. J. Purcell, O. Shelley, S. J. Kriynovich, E. Lien, J. A. Mannick, and J. A. Lederer. 2003. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol. 171: 1473-1483.
10. Baca-Estrada, M. E., C. Ewen, D. Mahony, L. A. Babiuk, D. Wilkie, and M. Foldvari. 2002. The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization. Immunology 107: 69-76.
11. Nayak, B. P., G. Sailaja, and A. M. Jabbar. 2006. Augmenting the immunogenicity of DNA vaccines: role of plasmid-encoded Flt-3 ligand, as a molecular adjuvant in genetic vaccination. Virology 348: 277-288.
12. Dong, J., C. M. McPherson, and P. J. Stambrook. 2002. Flt-3 ligand: a potent dendritic cell stimulator and novel antitumor agent. Cancer Biol. Ther. 1: 486-489.
13. Kremer, I. B., M. P. Gould, K. D. Cooper, and F. P. Heinzel. 2001. Pretreatment with recombinant Flt3 ligand partially protects against progressive cutaneous leishmaniasis in susceptible BALB/c mice. Infect. Immun. 69: 673-680.
14. Smith, J. R., A. M. Thackray, and R. Bujdoso. 2001. Reduced herpes simplex virus type 1 latency in Flt-3 ligand-treated mice is associated with enhanced numbers of natural killer and dendritic cells. Immunology 102: 352-358.
15. Vollstedt, S., M. Franchini, H. P. Hefti, B. Odermatt, M. O'Keeffe, G. Alber, B. Glanzmann, M. Riesen, M. Ackermann, and M. Suter. 2003. Flt3 ligand-treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J. Exp. Med. 197: 575-584.
16. - dendritic cells in vivo. J. Exp. Med. 198: 305-313.
17. Fernandez, N. C., C. Flament, F. Crepineau, E. Angevin, E. Vivier, and L. Zitvogel. 2002. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur. Cytokine Netw. 13: 17-27.
18. Granucci, F., S. Feau, I. Zanoni, N. Pavelka, C. Vizzardelli, G. Raimondi, and P. Ricciardi-Castagnoli. 2003. The immune response is initiated by dendritic cells via interaction with microorganisms and interleukin-2 production. J. Infect. Dis. 187: S346-S350.
19. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
20. Ohteki, T., T. Fukao, K. Suzue, C. Maki, M. Ito, M. Nakamura, and S. Koyasu. 1999. Interleukin 12-dependent interferon γ production by CD8alpha+ lymphoid dendritic cells. J. Exp. Med. 189: 1981-1986.
21. Larsen, C. P., S. C. Ritchie, T. C. Pearson, P. S. Linsley, and R. P. Lowry. 1992. Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J. Exp. Med. 176: 1215-1220.
22. McLellan, A. D., R. V. Sorg, L. A. Williams, and D. N. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur. J. Immunol. 26: 1204-1210.
23. Agrawal, D. K., M. T. Hopfenspirger, J. Chavez, and J. E. Talmadge. 2001. Flt3 ligand: a novel cytokine prevents allergic asthma in a mouse model. Int. Immunopharmacol. 1: 2081-2089.
24. Pabst, R., A. Luhrmann, I. Steinmetz, and T. Tschernig. 2003. A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production. J. Immunol. 171: 325-330.
25. Parajuli, P., R. L. Mosley, V. Pisarev, J. Chavez, A. Ulrich, M. Varney, R. K. Singh, and J. E. Talmadge. 2001. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Exp. Hematol. 29: 1185-1193.
26. Pulendran, B., J. L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C. R. Maliszewski. 1998. Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant. J. Exp. Med. 188: 2075-2082.
27. Wysocka, M., L. J. Montaner, and C. L. Karp. 2005. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J. Immunol. 174: 7398-7402.
28. Toliver-Kinsky, T. E., W. Cui, E. D. Murphey, C. Lin, and E. R. Sherwood. 2005. Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J. Immunol. 174: 404-410.
29. Chalekson, C. P., M. W. Neumeister, and J. Jaynes. 2002. Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plastic Reconstructive Surg. 109: 1338-1343.
30. Gamelli, R. L., L. K. He, H. Liu, and J. D. Ricken. 1998. Burn wound infection-induced myeloid suppression: the role of prostaglandin E2, elevated adenylate cyclase, and cyclic adenosine monophosphate. J. Trauma 44: 469-474.
31. Guo, Z., E. Kavanagh, Y. Zang, S. M. Dolan, S. J. Kriynovich, J. A. Mannick, and J. A. Lederer. 2003. Burn injury promotes antigen-driven Th2-type responses in vivo. J. Immunol. 171: 3983-3990.
32. Armour, A. D., H. A. Shankowsky, T. Swanson, J. Lee, and E. E. Tredget. 2007. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J. Trauma 63: 164-171.
33. Dalley, A. J., J. Lipman, B. Venkatesh, M. Rudd, M. S. Roberts, and S. E. Cross. 2007. Inadequate antimicrobial prophylaxis during surgery: a study of β-lactam levels during burn debridement. J. Antimicrob. Chemother. 60: 166-169.
34. Rodgers, G. L., J. Mortensen, M. C. Fisher, A. Lo, A. Cresswell, and S. S. Long. 2000. Predictors of infectious complications after burn injuries in children. Pediat. Infect. Dis. J. 19: 990-995.
35. Still, J., T. Newton, B. Friedman, S. Furhman, E. Law, and J. Dawson. 2000. Experience with pneumonia in acutely burned patients requiring ventilator support. American Surgeon 66: 206-209.
36. Toliver-Kinsky, T. E., C. Y. Lin, D. N. Herndon, and E. R. Sherwood. 2003. Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice. Infect. Immun. 71: 3058-3067.
37. Lim, L. C., M. N. Fiordalisi, J. L. Mantell, J. L. Schmitz, and J. D. Folds. 1998. A whole-blood assay for qualitative and semiquantitative measurements of CD69 surface expression on CD4 and CD8 T lymphocytes using flow cytometry. Clin. Diagn. Lab Immunol. 5: 392-398.
38. Scott, M. J., J. J. Hoth, M. Turina, D. R. Woods, and W. G. Cheadle. 2006. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection. Cytokine 33: 79-86.
39. Bieber, T., A. Rieger, G. Stingl, E. Sander, P. Wanek, and I. Strobel. 1992. CD69, an early activation antigen on lymphocytes, is constitutively expressed by human epidermal Langerhans cells. J. Invest. Dermatol. 98: 771-776.
40. Murphey, E. D., E. R. Sherwood, and T. E. Toliver-Kinsky. 2007. The immunological response and strategies for intervention. In Total Burn Care, 3rd edition. D. N. Herndon, ed. Edinburgh, Elsevier, p. 310.
41. Esche, C., V. M. Subbotin, O. Hunter, J. M. Peron, C. Maliszewski, M. T. Lotze, and M. R. Shurin. 1999. Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligand. J. Invest. Dermatol. 113: 1028-1032.
42. Hubert, P., L. Bousarghin, R. Greimers, E. Franzen-Detrooz, J. Boniver, and P. Delvenne. 2005. Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro. Exp. Dermatol. 14: 469-477.
43. Mende, I., H. Karsunky, I. L. Weissman, E. G. Engleman, and M. Merad. 2006. Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood 107: 1383-1390.
44. Park, J. E., and A. Barbul. 2004. Understanding the role of immune regulation in wound healing. Am. J. Surg. 187: 11S-16S.
45. Ward, B. R., J. V. Jester, A. Nishibu, M. Vishwanath, D. Shalhevet, T. Kumamoto, W. M. Petroll, H. D. Cavanagh, and A. Takashima. 2007. Local thermal injury elicits immediate dynamic behavioural responses by corneal Langerhans cells. Immunology 120: 556-572.
46. Gibran, N. S., D. M. Heimbach, and K. A. Holbrook. 1995. Immunolocalization of FXIIIa+ dendritic cells in human burn wounds. J. Surg. Res. 59: 378-386.
47. Hemmi, H., M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J. J. Letterio, T. Nakabayashi, H. Tagaya, et al. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol. 13: 695-704.
48. Simms, P. E., and T. M. Ellis. 1996. Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin. Diagn. Lab. Immunol. 3: 301-304.
49. Shimada, S., M. Nakamura, Y. Tanaka, K. Tsutsumi, M. Katano, K. Masuko, K. Yudoh, I. Koizuka, and T. Kato. 2007. Crosslinking of the CD69 molecule enhances S100A9 production in activated neutrophils. Microbiol. Immunol. 51: 87-98.
50. Lamana, A., D. Sancho, A. Cruz-Adalia, G. M. del Hoyo, A. M. Herrera, M. Feria, F. Díaz-González, M. Gómez, and F. Sánchez-Madrid. 2006. The role of CD69 in acute neutrophil-mediated inflammation. Eur. J. Immunol. 36: 2632-2638.
51. Sancho, D., M. Gómez, and F. Sánchez-Madrid. 2005. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26: 136-140.
52. Afeltra, A., M. Galeazzi, G. D. Sebastiani, G. M. Ferri, D. Caccavo, M. A. Addessi, R. Marcolongo, and L. Bonomo. 1997. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis. Int. J. Exp. Pathol. 78: 331-336.
53. + T lymphocytes in normal pregnancies. Mol. Hum. Reprod. 8: 667-673.
54. Lang, J., and D. Bellgrau. 2002. A T-cell functional phenotype common among autoimmune-prone rodent strains. Scand. J. Immunol. 55: 546-559.
55. Efron, P. A., A. Martins, D. Minnich, K. Tinsley, R. Ungaro, F. R. Bahjat, R. Hotchkiss, M. Clare-Salzler, and L. L. Moldawer. 2004. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J. Immunol. 173: 3035-3043.
56. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, M. H. Grayson, D. F. Osborne, T. H. Wagner, J. P. Cobb, C. Coopersmith, and I. E. Karl. 2002. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168: 2493-2500.
57. Wesche, D. E., J. L. Lomas-Neira, M. Perl, C. S. Chung, and A. Ayala. 2005. Leukocyte apoptosis and its significance in sepsis and shock. J. Leukocyte Biol. 78: 325-337.
58. Chen, L., K. V. Rao, Y. X. He, and K. Ramaswamy. 2002. Skin-stage schistosomula of Schistosoma mansoni produce an apoptosis-inducing factor that can cause apoptosis of T cells. J. Biol. Chem. 277: 34329-34335.
59. Colino, J., and C. M. Snapper. 2003. Opposing signals from pathogen-associated molecular patterns and IL-10 are critical for optimal dendritic cell induction of in vivo humoral immunity to Streptococcus pneumoniae. J. Immunol. 171: 3508-3519.
60. Alexander, M., I. H. Chaudry, and M. G. Schwacha. 2002. Relationships between burn size, immuno suppression, and macrophage hyperactivity in a murine model of thermal injury. Cell. Immunol. 220: 63-69.
61. Cohen, M. J., C. Carroll, L. K. He, K. Muthu, R. L. Gamelli, S. B. Jones, and R. Shankar. 2007. Severity of burn injury and sepsis determines the cytokine responses of bone marrow progenitor-derived macrophages. J. Trauma. 62: 858-867.
62. Noel, J. G., A. Osterburg, Q. Wang, X. Guo, D. Byrum, S. Schwemberger, H. Goetzman, C. C. Caldwell, and C. K. Ogle. 2007. Thermal injury elevates the inflammatory monocyte subpopulation in multiple compartments. Shock 28: 684-693.
63. Jefford, M., M. Schnurr, T. Toy, K. A. Masterman, A. Shin, T. Beecroft, T. Y. Tai, K. Shortman, M. Shackleton, I. D. Davis, et al. 2003. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 102: 1753-1763.
64. Gabbianelli, M., E. Pelosi, E. Montesoro, M. Valtieri, L. Luchetti, P. Samoggia, L. Vitelli, T. Barberi, U. Testa, S. Lyman, et al. 1995. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 86: 1661-1670.